Hereditary spherocytosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 62: | Line 62: | ||
== [[hereditary spherocytosis secondary prevention|Secondary Prevention]]== | == [[hereditary spherocytosis secondary prevention|Secondary Prevention]]== | ||
== [[hereditary spherocytosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] == | |||
== [[hereditary spherocytosis future or investigational therapies|Future or Investigational Therapies]] == | |||
== [[Hereditary spherocytosis case study one|Case Studies]] == | == [[Hereditary spherocytosis case study one|Case Studies]] == | ||
Revision as of 17:18, 28 November 2018
Template:DiseaseDisorder infobox
|
Hereditary spherocytosis Microchapters |
|
Differentiating Hereditary spherocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hereditary spherocytosis On the Web |
|
American Roentgen Ray Society Images of Hereditary spherocytosis |
|
Risk calculators and risk factors for Hereditary spherocytosis |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Zahir Ali Shaikh, MD[2]
Overview
Hereditary spherocytosis is a genetically-transmitted form of spherocytosis, an auto-hemolytic anemia characterized by the production of red blood cells that are sphere-shaped rather than donut-shaped, and therefore more prone to hemolysis.